Koninklijke Philips | PHG - Cost Of Sales


Koninklijke Philips reported EUR2.14B in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Abbott USD 5.94B 642M Jun/2026
Baxter International USD 1.93B 118M Jun/2026
Becton, Dickinson and Co. USD 2.56B 281M Mar/2026
Boston Scientific USD 1.86B 29M Jun/2026
Danaher USD 2.65B 294M Jun/2026
Demant DKK 2.89B 188M Dec/2025
Dexcom USD 478.4M 36.8M Jun/2026
Edwards Lifesciences USD 392.4M 29.8M Jun/2026
Fresenius EUR 4.45B 262M Dec/2025
General Electric Aerospace USD 8.89B 736M Jun/2026
Getinge SEK 3.97B 2.05B Jun/2026
Globus Medical USD 263.59M 26.88M Mar/2026
GN Store Nord DKK 1.16B 1.08B Mar/2026
Hitachi JPY 1.9T 240.43B Jun/2026
Idexx Laboratories USD 437.5M 19.42M Jun/2026
Insulet USD 232.7M 17.5M Mar/2026
Integra LifeSciences USD 188.86M 10.15M Jun/2026
Intuitive Surgical USD 931.9M 8.4M Jun/2026
J&J USD 8B 67M Jun/2026
Koninklijke Philips EUR 2.14B 1.13B Mar/2026
Medtronic USD 3.8B 195M Mar/2026
Philips EUR 2.21B 70M Jun/2026
ResMed USD 551.67M 4.17M Mar/2026
Smith & Nephew USD 901M 31M Jun/2026
Steris USD 891.3M 50.6M Mar/2026
Stryker USD 2.26B 106M Jun/2026
Teleflex USD 240.84M 20.7M Mar/2026
Terumo JPY 151.3B 7.86B Mar/2026
Zimmer Biomet Holdings USD 738.3M 231.8M Mar/2026